Loading
Total declarations
Companies
▲ Purchases (15 ops.)
▼ Sales (35 ops.)
Latest filing published 17 Sept 2026 for WuXi Biologics (Cayman) Inc., €6.5M.
Filing timeline
BuySaleChen Zhisheng
Insider track record
Disclosed buys
15
Disclosed sells
35
Signal history
Closed purchases
Market purchases
15
Positive at T+90
0%
Median T+90
-33.5%
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +41.7%Entry HK$34.86 · Close 21 Oct 2026 HK$49.40
- -12.0%Entry HK$27.90 · Close at T+365 HK$24.55
- -20.4%Entry HK$91.25 · Close at T+365 HK$72.60
- -40.5%Entry HK$88.00 · Close at T+365 HK$52.35
- -51.8%Entry HK$105.70 · Close at T+365 HK$50.95
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Chen Zhisheng: trading record in brief
Chen Zhisheng is Director of WuXi Biologics (Cayman) Inc. (114 filings) and WuXi XDC Cayman Inc. (3), two companies listed on the Hong Kong stock exchange. The file counts 117 filings published from June 11, 2019 to September 17, 2026, including 67 other filings.
The sales weigh heavily: 35 sales for EUR 344,829,620, a median of EUR 7,890,950, including EUR 36,293,904 on September 9, 2025, EUR 32,449,344 on June 24, 2021 and EUR 25,135,953 on September 10, 2025. Of the 15 purchases, only 5 carry an amount: EUR 12,099,614 in total, including EUR 4,274,851 on November 4, 2021, EUR 2,422,573 on December 16, 2021 and EUR 2,264,597 on November 9, 2021. Purchases are 30% of market trades.
2025 holds 43 filings, ahead of 2026 (17). In the last twelve months, 46 filings were published, with 2 purchases and 18 sales. The publication delay is a median of 4 days. Zhisheng has 21, 15 and 12 own market trades within 30 days of colleagues at WuXi Biologics (Cayman) Inc., in that order. Same direction: 19, 15 and 7. Names in order: Zhou Weichang, Gu Sherry Xuejun and Li Ge.
Companies and markets linked to Chen Zhisheng
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations117 total
1,200,000 shares@ HK$49.13590.029% mcap1.7% of flowShareXHKGHKEX:DA20260916E00540
1,200,000 shares@ HK$2.63670.0015% mcap0.1% of flowShareXHKGHKEX:DA20260914E00530
1,800,090 shares@ HK$49.03680.043% mcap2.6% of flowShareXHKGHKEX:DA20260914E00529
3,200,000 shares@ HK$49.38530.077% mcap4.6% of flowShareXHKGHKEX:DA20260911E00662
1,800,090 shares@ HK$2.63670.0023% mcap0.1% of flowShareXHKGHKEX:DA20260910E00390
2,400,000 shares@ HK$50.54490.059% mcap3.6% of flowShareXHKGHKEX:DA20260910E00389
1,500,000 shares@ HK$49.14080.035% mcap2.2% of flowShareXHKGHKEX:DA20260909E00596
3,200,000 shares@ HK$2.63670.0040% mcap0.2% of flowShareXHKGHKEX:DA20260909E00597
2,400,000 shares@ HK$2.63670.0030% mcap0.2% of flowShareXHKGHKEX:DA20260908E00492
1,500,000 shares@ HK$2.63670.0018% mcap0.8% of flowShareXHKGHKEX:DA20260907E00497
104,495 sharesShareXHKGHKEX:DA20260827E00572
378,080 sharesShareXHKGHKEX:DA20260622E00526
264,866 sharesShareXHKGHKEX:DA20260615E00437
148,127 sharesShareXHKGHKEX:DA20260401E00525
1,442,769 sharesShareXHKGHKEX:DA20260330E00499
Canonical exit: 23 Jun 2026 (T+90)
54,838 sharesShareXHKGHKEX:DA20260330E00500
Canonical exit: 23 Jun 2026 (T+90)
18,902,528 sharesShareXHKGHKEX:DA20260105E00245
8,800,000 sharesShareXHKGHKEX:DA20251223E00029
4,000,000 sharesShareXHKGHKEX:DA20251215E00402
3,160,723 shares@ HK$31.22242.9% of flowShareXHKGHKEX:DA20251205E00546
10,059,000 shares@ HK$1.29330.4% of flowShareXHKGHKEX:DA20251202E00262
1,563,177 shares@ HK$31.98131.5% of flowShareXHKGHKEX:DA20251202E00261
3,126,654 shares@ HK$31.85573.0% of flowShareXHKGHKEX:DA20251202E00260
3,000,000 shares@ HK$1.29330.1% of flowShareXHKGHKEX:DA20251128E00378
6,000,000 shares@ HK$1.29330.2% of flowShareXHKGHKEX:DA20251128E00376
25 of 117 declarations
